The diagnosis and treatment of urogenital schistosomiasis in Italy in a retrospective cohort of immigrants from Sub-Saharan Africa
To evaluate ultrasound and praziquantel to, respectively, assess and reduce urogenital schistosomiasis (UGS)-associated morbidity in migrants from Sub-Saharan Africa (SSA).
Migrants from SSA with UGS attending three Italian centres for tropical diseases during 2011–2016 were retrospectively enrolled. Data on clinical symptoms, routine laboratory, parasitological tests, and ultrasound reported as per the WHO–Niamey protocol were collected at baseline and at available follow-up visits after treatment with praziquantel 40 mg/kg/day for 3 days.
One hundred and seventy patients with UGS were enrolled and treated with praziquantel. Baseline ultrasonography showed urinary tract abnormalities in 115/169 patients (68%); the mean global Schistosoma haematobium score was 2.29 (SD 2.84, IQR 0–2), the mean urinary bladder intermediate score 1.75 (SD 1.73, IQR 0–2), and the mean upper urinary tract intermediate score 0.54 (SD 2.37, IQR 1–10). Abnormalities were more common among the 111 (65%) who were symptomatic (p < 0.02; OR 2.53; 95% CI 1.19–5.35). Symptoms started in 94/111 (85%) before arriving (median 63 months, IQR 12–119). At follow-up, we observed a significant reduction in the prevalence of UGS-related symptoms, blood, urine, and ultrasound abnormalities.
Our study results support the use of ultrasound and praziquantel for assessing and reducing UGS-associated morbidity in migrants. Health-seeking behaviour, diagnostic, and treatment delays contribute to the advanced pathology and qualified treatment success. To ensure earlier treatment, based on our findings, clinical experience, and available literature, we propose an algorithm for the diagnosis and clinical management of UGS. Multicentre studies are needed to improve the management of subjects with UGS in non-endemic countries.
KeywordsSchistosoma Schistosomiasis Migrant Praziquantel Ultrasonography Ultrasound
This research did not receive any specific Grant from funding agencies in the public, commercial, or not-for-profit sectors.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100:1–441.Google Scholar
- 6.IAMAT. World schistosomiasis risk chart. 2015. Available online: https://www.iamat.org/elibrary/view/id/2969#. Accessed 6 Jan 2019.
- 10.World Health Organization. Schistosomiasis—current estimated total number of individuals with morbidity and mortality due to Schistosomiasis haematobium and S. mansoni infection in Sub-Saharan Africa. 2018. http://www.who.int/schistosomiasis/epidemiology/table/en/. Accessed: 26 July 2018.
- 11.Buonfrate D, Gobbi F, Marchese V, et al. Extended screening for infectious diseases among newly-arrived asylum seekers from Africa and Asia, Verona province, Italy, April 2014 to June 2015. Euro Surveill. 2018;23:17-00527. https://doi.org/10.2807/1560-7917.ES.2018.23.16.17-00527.CrossRefGoogle Scholar
- 19.Niamey Working Group, et al. Ultrasound in schistosomiasis. A practical guide to the standardized use of ultrasonography for the assessment of schistosomiasis-related morbidity. Geneva:World Health Organization;2000.Google Scholar
- 21.Centers for Disease Control and Prevention. Schistosomiasis. Resources for Health Professionals. 2012. https://www.cdc.gov/parasites/schistosomiasis/health_professionals/index.html. Accessed 26 July.
- 23.Ministero Dell’interno. I numeri dell’asilo. 2017. http://www.interno.gov.it/it/sala-stampa/dati-e-statistiche/i-numeri-dellasilo. Accessed 26 July.
- 24.ISTITUTO NAZIONALE PER LA PROMOZIONE DELLA SALUTE DELLE POPOLAZIONI MIGRANTI E PER IL CONTRASTO DELLE MALATTIE DELLA POVERTÀ. I controlli alla frontiera. La frontiera dei controlli. Controlli sanitari all’arrivo e percorsi di tutela per i migranti ospiti nei centri di accoglienza. 2017. http://www.inmp.it/lg/LG_Migranti-web.pdf. Accessed 6 Jan 2019.
- 25.U.S. Department of Health and Human Services, et al. Intestinal parasite guidelines for domestic medical examination for newly arrived refugees. 2013.Google Scholar
- 26.Chaves NJ, et al. The Australasian Society for Infectious Diseases and Refugee Health Network of Australia recommendations for health assessment for people from refugee-like backgrounds: an abridged outline. Med J Aust. 2017;206:310–315. (ISSN 1326–5377 (Electronic) 0025-729X (Linking)).CrossRefGoogle Scholar
- 27.Pottie K, et al. Evidence-based clinical guidelines for immigrants and refugees. Cmaj. 2011;183:E824–925. (ISSN 1488–2329 (Electronic) 0820–3946 (Linking)).Google Scholar
- 37.Giboda M, Smith JM. Schistosoma mansoni eggs as a target for praziquantel: efficacy of oral application in mice. J Trop Med Hyg. 1994;97:98–102. (ISSN 0022–5304 (Print) 0022–5304).Google Scholar
- 44.Cioli D, Pica-Mattoccia L. Praziquantel. Parasitol Res. 2003;90:S3–9. (ISSN 0932–0113 (Print) 0932–0113).Google Scholar